In the preceding three months, 23 analysts have released ratings for Eli Lilly and Co (NYSE:LLY), presenting a wide array of perspectives from bullish to bearish.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 5 | 16 | 2 | 0 | 0 |
Last 30D | 1 | 0 | 0 | 0 | 0 |
1M Ago | 1 | 5 | 1 | 0 | 0 |
2M Ago | 1 | 1 | 0 | 0 | 0 |
3M Ago | 2 | 10 | 1 | 0 | 0 |
In the assessment of 12-month price targets, analysts unveil insights for Eli Lilly and Co, presenting an average target of $833.91, a high estimate of $1000.00, and a low estimate of $630.00. Marking an increase of 14.42%, the current average surpasses the previous average price target of $728.79.
Exploring Analyst Ratings: An In-Depth...
Login or create a forever free account to read this news
Sign up/Log in